Deals
U.S. Mergers Face Antitrust Delays Amid Virus Disruptions
- DOJ, FTC may seek extensions to complete investigations
- Allergan, Raytheon mergers among those needing antitrust nods
This article is for subscribers only.
Companies seeking U.S. approval for mergers could face delays in completing their deals as federal antitrust officials seek extra time to complete reviews amid disruptions caused by the coronavirus.
The Justice Department’s antitrust division said in a statement Tuesday that it will ask companies for an additional 30 days for merger reviews that are in their final stages. The Federal Trade Commission said it will seek extensions as needed.